William Blair Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163M Buy
2,525,975
+683,019
+37% +$48.1M 0.54% 46
2025
Q4
$124M Buy
+1,842,956
New +$124M 0.35% 78
2023
Q1
Sell
-3,706,003
Closed -$211M 406
2022
Q4
$211M Sell
3,706,003
-730,081
-16% -$37.4M 0.81% 31
2022
Q3
$175M Sell
4,436,084
-130,787
-3% -$5.78M 0.69% 45
2022
Q2
$201M Sell
4,566,871
-773,020
-14% -$33.4M 0.74% 34
2022
Q1
$213M Buy
5,339,891
+266,226
+5% +$9.48M 0.64% 46
2021
Q4
$204M Buy
5,073,665
+76,957
+2% +$2.87M 0.55% 60
2021
Q3
$203M Buy
4,996,708
+114,222
+2% +$4.78M 0.57% 55
2021
Q2
$222M Sell
4,882,486
-454,976
-9% -$20.1M 0.7% 46
2021
Q1
$223M Sell
5,337,462
-1,024,882
-16% -$46.8M 0.72% 46
2020
Q4
$272M Sell
6,362,344
-158,182
-2% -$5.69M 0.9% 26
2020
Q3
$171M Sell
6,520,526
-58,086
-0.9% -$1.62M 0.67% 58
2020
Q2
$176M Buy
6,578,612
+15,006
+0.2% +$339K 0.72% 48
2020
Q1
$118M Buy
6,563,606
+232,076
+4% +$4.4M 0.57% 55
2019
Q4
$112M Buy
6,331,530
+915,535
+17% +$15.9M 0.45% 72
2019
Q3
$84M Buy
5,415,995
+1,877,068
+53% +$30.9M 0.36% 87
2019
Q2
$60.8M Buy
3,538,927
+3,134,003
+774% +$50.6M 0.26% 108
2019
Q1
$6.52M Buy
+404,924
New +$6.56M 0.03% 334

Other funds holding HALO

William Blair Investment Management's HALO Position: Q1 2026 in Review

William Blair Investment Management increased its Halozyme (HALO) stake by 37% in Q1 2026, buying an estimated $48.1M and bringing the position to 2,525,975 shares worth $163M. The position accounts for 0.54% of the portfolio, ranked #46.

William Blair Investment Management first reported a position in HALO in Q1 2019 and has held it in 18 quarters since. The position peaked at $272M in Q4 2020. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • William Blair Investment Management held 2,525,975 shares of Halozyme worth $163M as of Q1 2026.
  • William Blair Investment Management bought 683,019 Halozyme shares in Q1 2026, an estimated $48.1M.
  • Halozyme made up 0.54% of William Blair Investment Management's portfolio in Q1 2026, its #46 holding.
  • William Blair Investment Management first reported a position in Halozyme in Q1 2019 and has held it in 18 quarters since.
  • William Blair Investment Management's Halozyme position peaked at $272M in Q4 2020.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.